ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 306107 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 306107; 2) Community: the network communities that were significantly associated with the response to NSC 306107; 3) Molecule: the relationships between components within communities and NSC 306107; 4) MDR: the compounds that were significantly associated with the NSC 306107.

NSC Compound Enrichment Correlation
NSC 671765 3-[2-pyrrolidino] ethoxy-17-butyl-17-aza-1,3,5(10)-estratriene-16,17.alpha.-dione 0.049093561024907 0.00088359828
NSC 671869 Null 0.049093561024907 0.30159061
NSC 672974 Null 0.049093561024907 -0.1394126
NSC 676466 Null 0.049093561024907 0.030999635
NSC 677586 Null 0.049093561024907 -0.0061970314
NSC 677784 Null 0.049093561024907 0.12566894
NSC 679035 1,8-Naphthyridin-4(1H)-one, 2-(3-chlorophenyl)-5-methyl- 0.049093561024907 0.048076415
NSC 681632 Camptothecin Derivative 0.049093561024907 0.093746511
NSC 681633 Camptothecin Derivative 0.049093561024907 0.16005897
NSC 683517 8H-Thieno[2,3-b]pyrrolizinium, 3-(4-bromophenyl)-4-methyl- 8-(1-pyrrolidinyl)-, iodide 0.049093561024907 0.56693795
Total:120  Current:117    [First] [Prev] [Next] [Last]